Concepedia

Novel Dual Action AT1 and ETA Receptor Antagonists Reduce Blood Pressure in Experimental Hypertension

Mark C. Kowala, Natesan Murugesan, John E. Tellew, Kenneth E. Carlson, Hossain Monshizadegan, Carol S. Ryan, Zhengxiang Gu, Bridgette Kane, Leena Fadnis, Rose A. Baska,

Journal of Pharmacology and Experimental Therapeutics · 2004 · 52 citations · 33 references

DOI

Concepts

References

33

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

Masashi Yanagisawa, Hiroki Kurihara, Sadao Kimura et al. · Nature · 1988 · 10.8K citations · Full text

, , +9

SOME QUANTITATIVE USES OF DRUG ANTAGONISTS

O. ARUNLAKSHANA, H. O. Schild · British Journal of Pharmacology and Chemotherapy · 1959 · 4K citations · Full text

, , +16

The Effect of an Endothelin-Receptor Antagonist, Bosentan, on Blood Pressure in Patients with Essential Hypertension

Henry Krum, Reuven J. Viskoper, Yves Lacourcière et al. · New England Journal of Medicine · 1998 · 573 citations · Full text

, , +16

Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells.

T Imai, Y Hirata, Toshiaki Emori et al. · Hypertension · 1992 · 357 citations

, , +7

Cellular mechanism of endothelin-1 release by angiotensin and vasopressin.

Toshiaki Emori, Y Hirata, Kazuki Ohta et al. · Hypertension · 1991 · 246 citations · Full text

, , +15